WuXiPharmaTechUTSouthwesternLydianNeurosciencesEliLillyCaseWesternReserveFund Inet IRRof 58.4%ApogenBiotechnologiesUniformedServicesUniversityDanaFarberCancerCorporateSpinoutsGeneYeo,Ph.D.RodeoTherapeuticsAcademic&ResearchInstitutionsARCHVenturePartnersSyndicationOperatingPartners?TheRockefellerUniversityOncologyNeuroscience& NeurologySubstantialExitHistory150+Years’ExperienceHarvardMedicalSchoolNewYorkOfficePronirasGatesFoundationDiversity$3.375BillionExit58.43%IRR$1 BillionGenentechCollaborationWeillCornellMedicineScientificExpertise1.02DPIhigh-quality,cutting edgelife sciencecompaniesAdvisory&CorporateBoardsCPRITVentureCapital2.85DVPITurn-KeyFacilitiesUTSouthwesternMedicalCenterPfizerVenturesReviewed >4,000OpportunitiesEntrepreneursDivestituresSingaporeOfficeSundarKodiyalamMDAndersonCancerCenterAbbviePennStateJanLundberg,Ph.D.(BARDA)– onupdatedslide deckColumbiaUniversityTachiYamada,M.D.LeroyHood,M.D.,Ph.D.Capital-efficiencyLodoTherapeuticsPetraPharmaSyndicationPartnersGatesFoundationTheRockefellerUniversityEmployeesScientists&TechnologyDevelopersAI &MachineLearningLewisCantleyCSABMembers?SeattleOfficeExceptionalTrackRecordMagnoliaNeurosciencesBruceL.A.Carter,Ph.D.$12.3MillionNIDAGrantWRFCapitalRodeoTherapeuticsTemasekNon-DilutiveFundingUniversityofMinnesota2014 Top-quartileRankedTop-tierInvestorsSteveGillis,Ph.D.AlexandriaVentureInvestmentsStrategicPartnershipsWeillCornellMedicineInfectiousDisease,Oncology,MicrobiomeLodoTherapeuticsTargetedTherapeutic(Asset)FinancingSanDiegoOfficeWuXiPharmaTechUTSouthwesternLydianNeurosciencesEliLillyCaseWesternReserveFund Inet IRRof 58.4%ApogenBiotechnologiesUniformedServicesUniversityDanaFarberCancerCorporateSpinoutsGeneYeo,Ph.D.RodeoTherapeuticsAcademic&ResearchInstitutionsARCHVenturePartnersSyndicationOperatingPartners?TheRockefellerUniversityOncologyNeuroscience& NeurologySubstantialExitHistory150+Years’ExperienceHarvardMedicalSchoolNewYorkOfficePronirasGatesFoundationDiversity$3.375BillionExit58.43%IRR$1 BillionGenentechCollaborationWeillCornellMedicineScientificExpertise1.02DPIhigh-quality,cutting edgelife sciencecompaniesAdvisory&CorporateBoardsCPRITVentureCapital2.85DVPITurn-KeyFacilitiesUTSouthwesternMedicalCenterPfizerVenturesReviewed >4,000OpportunitiesEntrepreneursDivestituresSingaporeOfficeSundarKodiyalamMDAndersonCancerCenterAbbviePennStateJanLundberg,Ph.D.(BARDA)– onupdatedslide deckColumbiaUniversityTachiYamada,M.D.LeroyHood,M.D.,Ph.D.Capital-efficiencyLodoTherapeuticsPetraPharmaSyndicationPartnersGatesFoundationTheRockefellerUniversityEmployeesScientists&TechnologyDevelopersAI &MachineLearningLewisCantleyCSABMembers?SeattleOfficeExceptionalTrackRecordMagnoliaNeurosciencesBruceL.A.Carter,Ph.D.$12.3MillionNIDAGrantWRFCapitalRodeoTherapeuticsTemasekNon-DilutiveFundingUniversityofMinnesota2014 Top-quartileRankedTop-tierInvestorsSteveGillis,Ph.D.AlexandriaVentureInvestmentsStrategicPartnershipsWeillCornellMedicineInfectiousDisease,Oncology,MicrobiomeLodoTherapeuticsTargetedTherapeutic(Asset)FinancingSanDiegoOffice

Home for the Holidays (& everyday) - Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
  1. WuXi PharmaTech
  2. UT Southwestern
  3. Lydian Neurosciences
  4. Eli Lilly
  5. Case Western Reserve
  6. Fund I net IRR of 58.4%
  7. Apogen Biotechnologies
  8. Uniformed Services University
  9. Dana Farber Cancer
  10. Corporate Spinouts
  11. Gene Yeo, Ph.D.
  12. Rodeo Therapeutics
  13. Academic & Research Institutions
  14. ARCH Venture Partners
  15. Syndication
  16. Operating Partners?
  17. The Rockefeller University
  18. Oncology
  19. Neuroscience & Neurology
  20. Substantial Exit History
  21. 150+ Years’ Experience
  22. Harvard Medical School
  23. New York Office
  24. Proniras
  25. Gates Foundation
  26. Diversity
  27. $3.375 Billion Exit
  28. 58.43% IRR
  29. $1 Billion Genentech Collaboration
  30. Weill Cornell Medicine
  31. Scientific Expertise
  32. 1.02 DPI
  33. high-quality, cutting edge life science companies
  34. Advisory & Corporate Boards
  35. CPRIT
  36. Venture Capital
  37. 2.85 DVPI
  38. Turn-Key Facilities
  39. UT Southwestern Medical Center
  40. Pfizer Ventures
  41. Reviewed > 4,000 Opportunities
  42. Entrepreneurs
  43. Divestitures
  44. Singapore Office
  45. Sundar Kodiyalam
  46. MD Anderson Cancer Center
  47. Abbvie
  48. Penn State
  49. Jan Lundberg, Ph.D.
  50. (BARDA) – on updated slide deck
  51. Columbia University
  52. Tachi Yamada, M.D.
  53. Leroy Hood, M.D., Ph.D.
  54. Capital-efficiency
  55. Lodo Therapeutics
  56. Petra Pharma
  57. Syndication Partners
  58. Gates Foundation
  59. The Rockefeller University
  60. Employees
  61. Scientists & Technology Developers
  62. AI & Machine Learning
  63. Lewis Cantley
  64. CSAB Members?
  65. Seattle Office
  66. Exceptional Track Record
  67. Magnolia Neurosciences
  68. Bruce L.A. Carter, Ph.D.
  69. $12.3 Million NIDA Grant
  70. WRF Capital
  71. Rodeo Therapeutics
  72. Temasek
  73. Non-Dilutive Funding
  74. University of Minnesota
  75. 2014 Top-quartile Ranked
  76. Top-tier Investors
  77. Steve Gillis, Ph.D.
  78. Alexandria Venture Investments
  79. Strategic Partnerships
  80. Weill Cornell Medicine
  81. Infectious Disease, Oncology, Microbiome
  82. Lodo Therapeutics
  83. Targeted Therapeutic (Asset) Financing
  84. San Diego Office